Precision Biosciences Inc (DTIL) Institutional Ownership

Ownership Summary

Precision Biosciences Inc (NASDAQ:DTIL) has 69 institutional investors that have filed 13F reports for the period ending December 2025.

• Collectively, these holders controlled 127.8% of Precision Biosciences's outstanding shares in December 2025, up from 39.3% in September 2025.
• They increased total shares held in Precision Biosciences by 287.24% from the prior quarter, while the number of investors in DTIL increased 25.45% year over year.
• Among the 69 funds, 43 bought more Precision Biosciences shares, 8 sold down, and 18 held their ground.
• Altogether, these fund groups held 15.11Mn shares in DTIL by December 2025, up by 11.21Mn shares quarter on quarter, and up 11.31Mn shares year over year.
• Octagon Capital Advisors LP leads ownership in DTIL with 2.24Mn shares as of December 31, 2025, equal to 18.93% of outstanding shares.
• Top purchasers of DTIL stock for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (910.74K), Affinity Asset Advisors, LLC (597.95K), MARSHALL WACE, LLP (344.76K), Octagon Capital Advisors LP (318.74K), DRIEHAUS CAPITAL MANAGEMENT LLC (207.67K).
• The biggest sellers of Precision Biosciences for the quarter ending December 2025 included Alyeska Investment Group, L.P. (659.18K), SPHERA FUNDS MANAGEMENT LTD. (356.12K), Empery Asset Management, LP (225.76K), RENAISSANCE TECHNOLOGIES LLC (103.3K), Quadrature Capital Ltd (29.85K).
• Per Business Quant data, the top 10 holders of Precision Biosciences for the quarter ending December 2025 are Octagon Capital Advisors LP (2.24Mn), Aberdeen Group plc (2.23Mn), Empery Asset Management, LP (1.97Mn), Bleichroeder LP (1.66Mn), BOOTHBAY FUND MANAGEMENT, LLC (1.07Mn), DRIEHAUS CAPITAL MANAGEMENT LLC (995.37K), Lynx1 Capital Management LP (985.11K), VANGUARD CAPITAL MANAGEMENT LLC (910.74K), Affinity Asset Advisors, LLC (597.95K), MARSHALL WACE, LLP (415.67K).